Exhibit 99.1

   Per-Se Technologies Announces Effectiveness of Debentures Resale
                        Registration Statement

    ALPHARETTA, Ga.--(BUSINESS WIRE)--March 14, 2005--Per-Se
Technologies, Inc. (Nasdaq:PSTI), the leader in Connective Healthcare
solutions that help physicians and hospitals realize their financial
goals, announced today that the Company's Registration Statement on
Form S-1 relating to the resale of its 3.25% convertible subordinated
debentures due 2024 and the common stock issuable, if any, upon
conversion of the debentures was declared effective at 5:30 p.m. ET on
March 14, 2005, by the Securities and Exchange Commission.
    As previously announced, the Company issued $125,000,000 aggregate
principal amount of the debentures to qualified institutional buyers
in a private placement in June 2004. At that time, the Company agreed
to register the debentures and all underlying shares of common stock
for resale. This registration process is now complete. The Company
will not receive any of the proceeds from any resale of the debentures
or any underlying shares of common stock.
    Copies of the prospectus for the debentures may be obtained from
Per-Se Technologies, Inc., Investor Relations Department, 1145
Sanctuary Parkway, Suite 200, Alpharetta, Ga., 30004, tel.:
770/237-4300, investors@per-se.com.
    This press release does not constitute an offer to sell or the
solicitation of an offer to buy securities, nor shall there be any
sale of these securities in any state in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such states.

    About Per-Se Technologies

    Per-Se Technologies (Nasdaq:PSTI) is the leader in Connective
Healthcare. Connective Healthcare solutions from Per-Se help enable
physicians and hospitals to achieve their income potential by creating
an environment that streamlines and simplifies the complex
administrative burden of providing healthcare. Per-Se's Connective
Healthcare solutions help reduce administrative expenses, increase
revenue and accelerate the movement of funds to benefit providers,
payers and patients. More information is available at www.per-se.com.

    CONTACT: For Per-Se Technologies
             Manning, Selvage & Lee
             Jim Storey, 404-870-6832
             jim.storey@mslpr.com